Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Cambrex Corporation

NYSE: CBMHealthcare / Biotechnology / USA
40.19+1.92+5.02%Vol 603 1761Y Perf -23.00%
Feb 21st, 2019 16:02
BID40.20 ASK40.21
Open38.18 Previous Close38.27
Pre-Market- After-Trading40.19
 - -%  - -%
Target Price
57.50 
Analyst Rating
Strong Buy 1.40
Potencial %
43.07 
Finscreener Ranking
★★★★+     59.67
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★★     70.03
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     69.45
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 351 
Earnings Rating
Buy
Price Range Ratio 52wk %
17.93 
Earnings Date
13th Feb 2019

Today's Price Range

38.1040.27

52wk Range

33.8069.43

5 Year PE Ratio Range

5.3033.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-6.03%
3 Months
-15.14%
6 Months
-36.36%
1 Year
-23.00%
3 Years
4.61%
5 Years
84.61%

Quotes

Name / TickerPriceChg.Chg.%
CBM40.191.92005.02
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.00
Current Ratio
4.50
Long Term Debt to Total Capital
0.33
Total Debt to Equity
0.49
Interest Coverage
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
39.10
EBIT Margin
24.80
EBITDA Margin
30.50
Pre-tax Profit Margin
22.40
Profit Margin
23.35
ValuationValueIndustryS&P 500US Markets
PE Ratio
10.60
PB Ratio
2.11
PS Ratios
3.08
Price to Cash Flow
12.00
Price to Free Cash Flow
-3.30
Cash Flow Per Share
3.47
Price to Tangible Book
7.10
Book Value per Share
19.64
Enterprise Value (in ths.)
1 618 260
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
21.34
ROE last 12 Months
22.82
Return on Assets (5Y Avg)
6.76
ROA last 12 Months
13.56
Return on Capital (5Y Avg)
20.68
ROC last 12 Months
14.55
Return on invested Capital Q
2.77
Return on invested Capital Y
21.56
Assets Turnover
0.40
Receivables Turnover
4.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
390 575
Revenue per Share
11.64
Revenue Growth 3 Years
-0.43
Revenue Growth 5 Years
7.56
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 20181.320.04-96.97
Q03 20180.590.7933.90
Q02 20180.661.2183.33
Q01 20180.500.7244.00
Q04 20171.101.2715.45
Q03 20170.470.5517.02
Q02 20170.750.761.33
Q01 20170.510.6833.33
Earnings Per EndEstimateRevision %Trend
12/2018 QR1.320.00-
12/2018 QR1.190.00-
12/2019 FY2.971.71Positive
12/2020 FY3.172.26Positive
Next Report Date-
Estimated EPS Next Report1.32
Estimates Count1
EPS Growth Next 5 Years %10.00
Volume Overview
Volume603 176
Shares Outstanding (in ths.)33 609
Trades Count3 146
Dollar Volume19 711 078
Avg. Volume462 705
Avg. Weekly Volume864 658
Avg. Monthly Volume530 895
Avg. Quarterly Volume439 675

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

51%49%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

There are no comments yet.

News